Published in JAMA on February 02, 1976
Hepatic heme metabolism and its control. Yale J Biol Med (1979) 1.02
Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias. Proc Natl Acad Sci U S A (1977) 0.93
Brain 5-aminolaevulinate synthase. Developmental aspects and evidence for regulatory role. Biochem J (1981) 0.84
A case of variegate porphyria in association with coeliac disease and bisphosphonate associated dental osteonecrosis. J Clin Med Res (2009) 0.75
Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature (1989) 5.10
Diminished support for linkage between manic depressive illness and X-chromosome markers in three Israeli pedigrees. Nat Genet (1993) 3.40
Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev (1999) 2.91
How well are complete dentures copied? Br Dent J (1998) 2.58
Expression and function of CD4 in a murine T-cell hybridoma. Nature (1987) 2.46
B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell (1987) 2.44
Factors affecting auditory performance of postlinguistically deaf adults using cochlear implants. Audiol Neurootol (1997) 2.03
A transgene containing lacZ inserted into the dystonia locus is expressed in neural tube. Nature (1988) 2.02
Tongue control of upper complete dentures: a clinical hint. Br Dent J (1991) 1.94
Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol (2001) 1.93
A genetic approach for analyzing the pathway of LamB assembly into the outer membrane of Escherichia coli. J Biol Chem (1991) 1.92
Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. Circulation (2000) 1.91
Myelination in the absence of myelin-associated glycoprotein. Nature (1994) 1.85
T-brain-1: a homolog of Brachyury whose expression defines molecularly distinct domains within the cerebral cortex. Neuron (1995) 1.84
Selected statistical issues in group randomized trials. Annu Rev Public Health (2001) 1.82
Phosphoinositide-specific phospholipase C-delta 1 binds with high affinity to phospholipid vesicles containing phosphatidylinositol 4,5-bisphosphate. Biochemistry (1992) 1.82
Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol Cell Neurosci (1998) 1.78
Evidence that smokeless tobacco use is a gateway for smoking initiation in young adult males. Prev Med (2001) 1.78
Capillary LC-MS2 at the attomole level for monitoring and discovering endogenous peptides in microdialysis samples collected in vivo. Anal Chem (2001) 1.71
Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase fusion protein. Neuron (1994) 1.69
Stat5 as a target for regulation by extracellular matrix. J Biol Chem (1995) 1.61
Evaluation of a macrofoam swab protocol for the recovery of Bacillus anthracis spores from a steel surface. Appl Environ Microbiol (2006) 1.56
Quantitative Differentiation of Minute Amounts of the Coproporphyrin Isomers (I and III) Based on Fluorescence Behavior. Science (1946) 1.50
Expression of the T-cell surface molecule CD2 and an epitope-loss CD2 mutant to define the role of lymphocyte function-associated antigen 3 (LFA-3) in T-cell activation. Proc Natl Acad Sci U S A (1988) 1.49
Cycle length dynamics at the onset of postinfarction ventricular tachycardias induced in canines: dependence on interval-dependent excitation properties of the reentrant substrate. J Cardiovasc Electrophysiol (2000) 1.48
The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med (1971) 1.47
Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) (1998) 1.46
THE CONVERSION OF HEMATIN TO BILIRUBIN FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMAN SUBJECTS. J Clin Invest (1945) 1.46
A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci U S A (1996) 1.46
Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J Exp Med (1988) 1.45
Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch Intern Med (1966) 1.43
Porphyria variegata and porphyria cutanea tarda in siblings: chemical and genetic aspects. Proc Natl Acad Sci U S A (1975) 1.43
Radioimmunoassay of mammalian type-C polypeptides. IV. Characterization of woolly monkey and gibbon viral antigens. Int J Cancer (1973) 1.42
Successful use of size-mismatched liver allografts in children by delayed primary closure of the abdominal wall. Br J Surg (1996) 1.39
A safe simple method for removal of the gallbladder through the umbilical trocar site during laparoscopic surgery. J Laparoendosc Surg (1994) 1.39
Potential dangers of laparoscopic insufflator. Lancet (1992) 1.39
A survey of complete denture prosthetics for the elderly, the handicapped and difficult patients. Br Dent J (1992) 1.37
The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv Exp Med Biol (2000) 1.34
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation (2000) 1.33
Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A (1971) 1.33
Efficient BLG-Cre mediated gene deletion in the mammary gland. Transgenic Res (1998) 1.33
The clinical porphyrias. Semin Hematol (1968) 1.28
NF-kappaB inhibits apoptosis in murine mammary epithelia. J Biol Chem (2000) 1.25
Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized? Circulation (1991) 1.25
Regulation of the sheep beta-lactoglobulin gene by lactogenic hormones is mediated by a transcription factor that binds an interferon-gamma activation site-related element. Mol Endocrinol (1994) 1.24
Effect of hematin in acute porphyric relapse. Ann Intern Med (1973) 1.19
Transitory renal failure following rapid administration of a relatively large amount of hematin in a patient with acute intermittent porphyria in clinical remission. Acta Med Scand (1978) 1.17
The flat-top gene is required for the expansion and regionalization of the telencephalic primordium. Development (1999) 1.17
Differential activation of STATs 3 and 5 during mammary gland development. FEBS Lett (1996) 1.17
Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol (2000) 1.16
Transient inhibition of interleukin 4 signaling by T cell receptor ligation. J Exp Med (2000) 1.16
Expression and function of CD8 in a murine T cell hybridoma. J Exp Med (1987) 1.16
Mutagenesis by chemical agents in V79 chinese hamster cells: a review and analysis of the literature. A report of the Gene-Tox Program. Mutat Res (1981) 1.15
Cellular mosaicism in the methylation and expression of hemizygous loci in the mouse. Genes Dev (1989) 1.15
Effects of hematin in hepatic porphyria. Further studies. Ann Intern Med (1975) 1.14
Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol (1999) 1.14
DNA chip technology. J Pathol (1999) 1.13
Identification and characterisation of a developmentally regulated mammalian gene that utilises -1 programmed ribosomal frameshifting. Nucleic Acids Res (2001) 1.12
Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine (1998) 1.10
Expression and assembly of a human neurofilament protein in transgenic mice provide a novel neuronal marking system. Genes Dev (1987) 1.09
Characterization of a nucleoside/proton symporter in procyclic Trypanosoma brucei brucei. J Biol Chem (1998) 1.08
Use of hematin in the acute attack of the "inducible" hepatic prophyrias. Adv Intern Med (1978) 1.07
Disrupted development of the cerebral hemispheres in transgenic mice expressing the mammalian Groucho homologue transducin-like-enhancer of split 1 in postmitotic neurons. Mech Dev (2000) 1.07
The structure and expression of the preproenkephalin gene. Nucleic Acids Res (1982) 1.06
Pituitary-specific expression and glucocorticoid regulation of a proopiomelanocortin fusion gene in transgenic mice. Proc Natl Acad Sci U S A (1988) 1.06
Differential regulation of nucleoside and nucleobase transporters in Crithidia fasciculata and Trypanosoma brucei brucei. Mol Biochem Parasitol (2000) 1.05
Apoptosis: the germs of death. Nat Cell Biol (1999) 1.05
Functional analysis of a cytoplasmic domain-deleted mutant of the CD4 molecule. J Immunol (1988) 1.04
Epigenetic and genetic factors affect transgene methylation imprinting. Development (1989) 1.04
Collagen-hyaluronic acid scaffolds for adipose tissue engineering. Acta Biomater (2010) 1.04
Cardiac responses to electrical stimulation of discrete loci in canine atrial and ventricular ganglionated plexi. Am J Physiol (1990) 1.04
Separation of bile pigments by thin layer chromatography. J Chromatogr (1968) 1.03
The mammary factor MPBF is a prolactin-induced transcriptional regulator which binds to STAT factor recognition sites. FEBS Lett (1994) 1.02
A new method of interpretation of the ferric chloride oxidation patterns of the urobilinoids. Arch Biochem Biophys (1969) 1.02
Mass spectrometry and ferric chloride oxidation applied to urobilinoid structures. Arch Biochem Biophys (1969) 1.01
A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland. Breast Cancer Res (2000) 1.01
A novel role for IRF-1 as a suppressor of apoptosis. Oncogene (2000) 1.00
The effect of WIC participation on small-for-gestational-age births: Michigan, 1992. Am J Public Health (1998) 1.00
The isolation of crystalline i-urobilinogen (mesobilirubinogen) from feces. Comparison with crystalline d-urobilinogen (H44) and seprartion of natural i-urobilin into optically active components. J Biol Chem (1966) 0.98
Posttransplant problems requiring regrafting: an analysis of 72 patients with 96 liver retransplants. Transplant Proc (1995) 0.98
Transcripts from an aberrantly re-arranged human T-cell receptor beta-chain gene. EMBO J (1985) 0.96
Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol (1996) 0.96
Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg (2001) 0.96
p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ (2001) 0.95
Staged diabetes management. Toward an integrated model of diabetes care. Diabetes Care (1994) 0.95
NF-kappaB and apoptosis in mammary epithelial cells. J Mammary Gland Biol Neoplasia (1999) 0.95